Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
11.8USD
−352.09 MUSD
26.82 MUSD
55.28 M
About Agios Pharmaceuticals, Inc.
Sector
CEO
Brian M. Goff
Headquarters
Cambridge
Website
Founded
2007
FIGI
BBG00JVRN4G3
Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in a research engine, multiple novels, and investigational therapies in preclinical development. It focuses on cellular metabolism and classical hematology. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 0HB0 is 45.0 USD — it has increased by 1.42% in the past 24 hours. Watch AGIOS PHARMACEUTICALS INC COM USD0.001 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange AGIOS PHARMACEUTICALS INC COM USD0.001 stocks are traded under the ticker 0HB0.
0HB0 stock has fallen by −2.05% compared to the previous week, the month change is a 9.29% rise, over the last year AGIOS PHARMACEUTICALS INC COM USD0.001 has showed a 111.93% increase.
We've gathered analysts' opinions on AGIOS PHARMACEUTICALS INC COM USD0.001 future price: according to them, 0HB0 price has a max estimate of 57.00 USD and a min estimate of 46.00 USD. Watch 0HB0 chart and read a more detailed AGIOS PHARMACEUTICALS INC COM USD0.001 stock forecast: see what analysts think of AGIOS PHARMACEUTICALS INC COM USD0.001 and suggest that you do with its stocks.
0HB0 reached its all-time high on Jul 19, 2018 with the price of 92.6 USD, and its all-time low was 17.0 USD and was reached on Jun 14, 2022. View more price dynamics on 0HB0 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
0HB0 stock is 2.07% volatile and has beta coefficient of 1.35. Track AGIOS PHARMACEUTICALS INC COM USD0.001 stock price on the chart and check out the list of the most volatile stocks — is AGIOS PHARMACEUTICALS INC COM USD0.001 there?
Today AGIOS PHARMACEUTICALS INC COM USD0.001 has the market capitalization of 2.56 B, it has increased by 2.71% over the last week.
Yes, you can track AGIOS PHARMACEUTICALS INC COM USD0.001 financials in yearly and quarterly reports right on TradingView.
AGIOS PHARMACEUTICALS INC COM USD0.001 is going to release the next earnings report on Feb 13, 2025. Keep track of upcoming events with our Earnings Calendar.
0HB0 earnings for the last quarter are 16.22 USD per share, whereas the estimation was 15.22 USD resulting in a 6.60% surprise. The estimated earnings for the next quarter are −1.67 USD per share. See more details about AGIOS PHARMACEUTICALS INC COM USD0.001 earnings.
AGIOS PHARMACEUTICALS INC COM USD0.001 revenue for the last quarter amounts to 9.00 M USD, despite the estimated figure of 9.44 M USD. In the next quarter, revenue is expected to reach 9.40 M USD.
0HB0 net income for the last quarter is 947.91 M USD, while the quarter before that showed −96.12 M USD of net income which accounts for 1.09 K% change. Track more AGIOS PHARMACEUTICALS INC COM USD0.001 financial stats to get the full picture.
No, 0HB0 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 5, 2024, the company has 383.00 employees. See our rating of the largest employees — is AGIOS PHARMACEUTICALS INC COM USD0.001 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AGIOS PHARMACEUTICALS INC COM USD0.001 EBITDA is −401.29 M USD, and current EBITDA margin is −1.43 K%. See more stats in AGIOS PHARMACEUTICALS INC COM USD0.001 financial statements.
Like other stocks, 0HB0 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AGIOS PHARMACEUTICALS INC COM USD0.001 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AGIOS PHARMACEUTICALS INC COM USD0.001 technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AGIOS PHARMACEUTICALS INC COM USD0.001 stock shows the buy signal. See more of AGIOS PHARMACEUTICALS INC COM USD0.001 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.